Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5697732 | Clinical Oncology | 2017 | 8 Pages |
Abstract
Urinary symptoms and uQoL as measured by the IPSS instrument remained stable or improved for the majority of men after definitive EBRT with or without ADT for prostate cancer. This was especially notable for the group of men with worse baseline symptoms or uQoL, with risk of persistent worsening of urinary symptoms decreasing with higher baseline IPSS category. Understanding the expected pattern of urinary symptoms and related uQoL in the months and years following EBRT taking into account baseline urinary function is highly valuable for counselling men as part of the therapeutic decision-making process.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Chin, A.J. Hayden, V. Gebski, S. Cross, S.L. Turner,